REQUEST A DEMO
Total
USD $0.00
Search more companies

Novo Nordisk Pharma Korea Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novo Nordisk Pharma Korea Ltd. Profile Updated: November 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Novo Nordisk Pharma Korea Ltd. is an enterprise in South Korea, with the main office in Incheon. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on May 03, 1994. It currently has a total number of 299 (2026) employees. From the latest financial highlights, Novo Nordisk Pharma Korea Ltd. reported a net sales revenue increase of 85.56% in 2025. A growth of 99.1% was recorded in its total assets. In, 2025, the company’s net profit margin increased by 0.1%.

Headquarters
16th Floor, 7-11, Sincheon-dong Songpa-gu Seoul
Incheon; Incheon; Postal Code: 05510

Contact Details: Purchase the Novo Nordisk Pharma Korea Ltd. report to view the information.

Website: http://www.novonordisk.com

Basic Information
Total Employees:
Purchase the Novo Nordisk Pharma Korea Ltd. report to view the information.
Outstanding Shares:
Purchase the Novo Nordisk Pharma Korea Ltd. report to view the information.
Registered Capital:
Purchase the Novo Nordisk Pharma Korea Ltd. report to view the information.
Financial Auditors:
Purchase the Novo Nordisk Pharma Korea Ltd. report to view the information.
Incorporation Date:
May 03, 1994
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novo Nordisk Pharma Korea Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
85.56%▲
Total Operating Revenue
85.56%▲
Operating Profit
77.13%▲
EBITDA
73.53%▲
Net Profit/Loss for the Period
92.51%▲
Total Assets
99.1%▲
Total Equity
31.2%▲
Operating Profit Margin
-0.16%▼
Net Profit Margin
0.1%▲
Return on Equity (ROE)
7.57%▲
Debt / Equity
-13.6%▼
Quick Ratio
-0.52%▼
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?